Express delivery and free returns within 21 days

Tuesday, June 28, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

4705 517227

Sample Post Title!

Sample Post Subtitle!

post content center img

Morbi libero lectus, laoreet elementum viverra vitae, sodales sit amet nisi. Vivamus dolor ipsum, ultrices in accumsan nec, viverra in nulla.

post content left img

Donec ligula sem, dignissim quis purus a, ultricies lacinia lectus. Aenean scelerisque, justo ac varius viverra, nisl arcu accumsan elit, quis laoreet metus ipsum vitae sem. Phasellus luctus imperdiet.

Donec tortor ipsum

Pharetra ac malesuada in, sagittis ac nibh. Praesent mattis ullamcorper metus, imperdiet convallis eros bibendum nec. Praesent justo quam, sodales eu dui vel, iaculis feugiat nunc.

Pellentesque faucibus orci at lorem viverra, id venenatis justo pretium. Nullam congue, arcu a molestie bibendum, sem orci lacinia dolor, ut congue dolor justo a odio.

post content right img

Duis odio neque, congue ut iaculis nec, pretium vitae libero. Cras eros ipsum, eleifend rhoncus quam at, euismod sollicitudin erat.

Fusce imperdiet, neque ut sodales dignissim, nulla dui. Nam vel tortor orci.

Subscribe to Medical Device News Magazine
Post author namePost author url
Post author biographical information.

Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing

Funds will be used to complete the first-in-human clinical study in Australia of the SirPlux Duo drug-coated balloon in de-novo coronary artery disease lesions notes Advanced NanoTherapies.

Centerline Biomedical Raises $33 Million in Series B Financing

Centerline Biomedical notes their flagship product, IOPS® (Intra-Operative Positioning System) was developed in Cleveland Clinic's Heart and Vascular Institute and utilizes patented algorithms to generate a patient-specific vascular map combined with electromagnetic tracking and smart sensor-equipped surgical devices to provide real-time, 3-D color visualization and navigation of the human vascular system.

MicroTransponder Raises $53M

MicroTransponder plans to use the funds to commercialize the Vivistim® Paired VNS™ System and establish it as the recommended rehabilitation intervention for stroke survivors working to improve their quality of life through more hand and arm mobility.

By using this website you agree to accept Medical Device News Magazine Privacy Policy